METHOD FOR DETECTION AND DIAGNOSIS OF CANCER INVOLVING PRIMER AND PROBE FOR SPECIFIC DETECTION OF MAGE-A3-MARKER

PROBLEM TO BE SOLVED: To provide an assay to identify patients having MAGE-A3 expressing tumor tissue who therefore benefits from MAGE-A3 specific immunotherapy.SOLUTION: The present invention relates to MAGE-A3 specific primers and probes for use in new diagnostic kits and methods. The invention fu...

Full description

Saved in:
Bibliographic Details
Main Authors OLIVIER GRUSELLE, SALONGA DENNIS, BEER GABRIELE ANNE-MARIE, THIERRY COCHE, STEPHENS CRAIG LAWRENCE
Format Patent
LanguageEnglish
Published 07.03.2013
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS OR TEST PAPERS THEREFOR
COMPOSITIONS THEREOF
CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES
CULTURE MEDIA
ENZYMOLOGY
MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PROCESSES OF PREPARING SUCH COMPOSITIONS
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:PROBLEM TO BE SOLVED: To provide an assay to identify patients having MAGE-A3 expressing tumor tissue who therefore benefits from MAGE-A3 specific immunotherapy.SOLUTION: The present invention relates to MAGE-A3 specific primers and probes for use in new diagnostic kits and methods. The invention further relates to immunotherapeutic treatment of specific populations of cancer patients, suffering from MAGE-A3 expressing tumors.
Bibliography:Application Number: JP20120245934